BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 14596591)

  • 1. Crystal structure of allo-Ile(A2)-insulin, an inactive chiral analogue: implications for the mechanism of receptor binding.
    Wan ZL; Xu B; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2003 Nov; 42(44):12770-83. PubMed ID: 14596591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiral mutagenesis of insulin's hidden receptor-binding surface: structure of an allo-isoleucine(A2) analogue.
    Xu B; Hua QX; Nakagawa SH; Jia W; Chu YC; Katsoyannis PG; Weiss MA
    J Mol Biol; 2002 Feb; 316(3):435-41. PubMed ID: 11866509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes-associated mutations in human insulin: crystal structure and photo-cross-linking studies of a-chain variant insulin Wakayama.
    Wan ZL; Huang K; Xu B; Hu SQ; Wang S; Chu YC; Katsoyannis PG; Weiss MA
    Biochemistry; 2005 Apr; 44(13):5000-16. PubMed ID: 15794638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.
    Huang K; Xu B; Hu SQ; Chu YC; Hua QX; Qu Y; Li B; Wang S; Wang RY; Nakagawa SH; Theede AM; Whittaker J; De Meyts P; Katsoyannis PG; Weiss MA
    J Mol Biol; 2004 Aug; 341(2):529-50. PubMed ID: 15276842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure and dynamics of a protein assembly. 1H-NMR studies of the 36 kDa R6 insulin hexamer.
    Jacoby E; Hua QX; Stern AS; Frank BH; Weiss MA
    J Mol Biol; 1996 Apr; 258(1):136-57. PubMed ID: 8613983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of an engineered insulin monomer at neutral pH.
    Olsen HB; Ludvigsen S; Kaarsholm NC
    Biochemistry; 1996 Jul; 35(27):8836-45. PubMed ID: 8688419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures.
    Hua QX; Hu SQ; Jia W; Chu YC; Burke GT; Wang SH; Wang RY; Katsoyannis PG; Weiss MA
    J Mol Biol; 1998 Mar; 277(1):103-18. PubMed ID: 9514738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational studies of heterochiral peptides with diastereoisomeric residues: crystal and molecular structures of linear dipeptides derived from leucine, isoleucine, and allo-isoleucine.
    Di Blasio B; Saviano M; Del Duca V; De Simone G; Rossi F; Pedone C; Benedetti E; Lorenzi GP
    Biopolymers; 1995 Oct; 36(4):401-8. PubMed ID: 7578937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chiral mutagenesis of insulin. Foldability and function are inversely regulated by a stereospecific switch in the B chain.
    Nakagawa SH; Zhao M; Hua QX; Hu SQ; Wan ZL; Jia W; Weiss MA
    Biochemistry; 2005 Apr; 44(13):4984-99. PubMed ID: 15794637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue.
    Hua QX; Hu SQ; Frank BH; Jia W; Chu YC; Wang SH; Burke GT; Katsoyannis PG; Weiss MA
    J Mol Biol; 1996 Nov; 264(2):390-403. PubMed ID: 8951384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-standard insulin design: structure-activity relationships at the periphery of the insulin receptor.
    Weiss MA; Wan Z; Zhao M; Chu YC; Nakagawa SH; Burke GT; Jia W; Hellmich R; Katsoyannis PG
    J Mol Biol; 2002 Jan; 315(2):103-11. PubMed ID: 11779231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A model for short alpha-neurotoxin bound to nicotinic acetylcholine receptor from Torpedo californica: comparison with long-chain alpha-neurotoxins and alpha-conotoxins.
    Mordvintsev DY; Polyak YL; Levtsova OV; Tourleigh YV; Kasheverov IE; Shaitan KV; Utkin YN; Tsetlin VI
    Comput Biol Chem; 2005 Dec; 29(6):398-411. PubMed ID: 16290328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the dynamic behavior of monomeric and dimeric insulin shows structural rearrangements in the active monomer.
    Zoete V; Meuwly M; Karplus M
    J Mol Biol; 2004 Sep; 342(3):913-29. PubMed ID: 15342246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structures of the R6 human insulin hexamer,
    Chang X; Jorgensen AM; Bardrum P; Led JJ
    Biochemistry; 1997 Aug; 36(31):9409-22. PubMed ID: 9235985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.
    Wan Z; Xu B; Huang K; Chu YC; Li B; Nakagawa SH; Qu Y; Hu SQ; Katsoyannis PG; Weiss MA
    Biochemistry; 2004 Dec; 43(51):16119-33. PubMed ID: 15610006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between insulin bioactivity and structure in the NH2-terminal A-chain helix.
    Olsen HB; Ludvigsen S; Kaarsholm NC
    J Mol Biol; 1998 Nov; 284(2):477-88. PubMed ID: 9813131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR solution structure of type II human cellular retinoic acid binding protein: implications for ligand binding.
    Wang L; Li Y; Abildgaard F; Markley JL; Yan H
    Biochemistry; 1998 Sep; 37(37):12727-36. PubMed ID: 9737849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes-associated mutations in insulin: consecutive residues in the B chain contact distinct domains of the insulin receptor.
    Xu B; Hu SQ; Chu YC; Huang K; Nakagawa SH; Whittaker J; Katsoyannis PG; Weiss MA
    Biochemistry; 2004 Jul; 43(26):8356-72. PubMed ID: 15222748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of the B-chain beta-turn in [GlyB24] insulin mutants: a steady-state fluorescence anisotropy study.
    Pittman I; Nakagawa SH; Tager HS; Steiner DF
    Biochemistry; 1997 Mar; 36(12):3430-7. PubMed ID: 9131992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of aliphatic side-chain structure at positions 2 and 3 of the insulin A chain in insulin-receptor interactions.
    Nakagawa SH; Tager HS
    Biochemistry; 1992 Mar; 31(12):3204-14. PubMed ID: 1554705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.